Commentary: The ALLHAT Study: implications for the management of resistant hypertension
- PMID: 15655384
- PMCID: PMC8109445
- DOI: 10.1111/j.1524-6175.2005.04302.x
Commentary: The ALLHAT Study: implications for the management of resistant hypertension
Similar articles
-
The ALLHAT and the cardioprotection conferred by diuretics in hypertensive patients: a connection with uric acid?Cardiovasc Drugs Ther. 2002 Dec;16(6):485-7. doi: 10.1023/a:1023090823731. Cardiovasc Drugs Ther. 2002. PMID: 12797357 No abstract available.
-
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications.Hypertension. 2003 May;41(5):1006-9. doi: 10.1161/01.HYP.0000070905.09395.F6. Epub 2003 Apr 14. Hypertension. 2003. PMID: 12695423 No abstract available.
-
ALLHAT and beyond.Am J Hypertens. 2003 Jun;16(6):512-4. doi: 10.1016/s0895-7061(03)00856-2. Am J Hypertens. 2003. PMID: 12799104 No abstract available.
-
ALLHAT: setting the record straight.Ann Intern Med. 2004 Jul 6;141(1):39-46. doi: 10.7326/0003-4819-141-1-200407060-00013. Ann Intern Med. 2004. PMID: 15238369 Review.
-
Comments on the renal aspects of the ALLHAT study.J Hypertens. 2003 Feb;21(2):235-6. doi: 10.1097/00004872-200302000-00005. J Hypertens. 2003. PMID: 12569244 Review. No abstract available.
References
-
- ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group . Major outcomes in high‐risk hypertensive patients randomized to angiotensin‐converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288: 2981–2997. - PubMed
-
- Moser M. Results of ALLHAT: is this the final answer regarding initial antihypertensive drug therapy? Arch Intern Med. 2003; 163: 1269–1273. - PubMed
-
- Black HR, Elliott WJ, Grandits G, et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE) trial. JAMA. 2003; 289: 2073–2082. - PubMed
-
- Hansson L, Zanchetti A, Carruthers SG, et al., for the HOT Study Group. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet. 1998; 351: 1755–1762. - PubMed
-
- Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003; 290: 199–206. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical